# Relative Abundance of <i>EGFR</i> Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non–Small-Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/relative-abundance-of-i-egfr-i-mutations-predicts-benefit-from-gefitinib/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Qing Zhou,Xu‐Chao Zhang,Zhihong Chen,Xiaolu Yin,Jin‐Ji Yang,Chong‐Rui Xu,Hong‐Hong Yan,Hua‐Jun Chen,Jian Su,Wen‐Zhao Zhong,Xue‐Ning Yang,Shejuan An,Bin-Chao Wang,Yi-Sheng Huang,Zhen Wang,Yi‐Long Wu |
| Citations | 247 |
| DOI | 10.1200/jco.2010.33.3757 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2134897113 |
| PMID | 21788562 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Qing Zhou](https://scholariq.org/researchers/qing-zhou/)
- [Hong‐Hong Yan](https://scholariq.org/researchers/hong-hong-yan/)
- [Chong‐Rui Xu](https://scholariq.org/researchers/chong-rui-xu/)
- [Xu‐Chao Zhang](https://scholariq.org/researchers/xu-chao-zhang/)
- [Wen‐Zhao Zhong](https://scholariq.org/researchers/wen-zhao-zhong/)
- [Jin‐Ji Yang](https://scholariq.org/researchers/jin-ji-yang/)
- [Yi‐Long Wu](https://scholariq.org/researchers/yi-long-wu/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.